The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...